Pharmaceutical / Drug Definition :
Inactivates neoplastic cells by alkylating DNA, causing DNA structural modification and fragmentation. Thought to act in late G1 or early S phase of cell cycle.
In the United States, Lomustine is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Lomustine.
Registrar Corp assists Lomustine companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Lomustine (Lomustine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Lomustine (Lomustine Suppliers)
- Processors Lomustine
- Repackers Lomustine
- Relabelers Lomustine
- Exporters Lomustine
- Importers Lomustine
For more information about Lomustine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.